Trial intelligence / Profile preview

Pain after thoracoscopic lung surgery – intercostal nerve block with standard vs liposomal bupivacaine

2021-003218-38Phase 2Terminated

Sponsor
Aalborg University Hospital
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of bupivacaine in acute postoperative pain and bronchial carcinoma (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Time to first postoperative administration of PRN opioids. Started Jul 2021; status: terminated.

02

Drugs

bupivacaine
03

Conditions

acute postoperative painbronchial carcinoma

Beyond the preview

Go deeper on 2021-003218-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-003218-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call